ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

Secoiridoid Glucosides and Anti-Inflammatory Constituents from the Stem Bark of Fraxinus chinensis.

ヤチダモ(Fraxinus chinensis)の樹皮由来のセコイリドイド配糖体と抗炎症成分 (機械翻訳の邦題)

Molecules (Basel, Switzerland)2020Chang HC, Wang SW, Chen CY, et al.
研究デザインその他の原著論文
対象ヒト・動物 併記

記録の確認項目

研究デザイン
その他の原著論文
対象
ヒト・動物 併記
出版年
2020
出典
doi.org
抄録の表示
表示あり
出版状態
有効な記録
状態確認日
2026/08/17
収集日
2026/08/03
鮮度
確認期限内
確認段階
自動処理
記録状態
公開

日本語要約(機械生成)

ヤチダモ(Fraxinus chinensis)の樹皮から、3種の新規セコイリドイド配糖体(1-3)と23種の既知化合物(4-26)を単離した。構造は各種スペクトル分析により決定した。単離化合物のうち、1、2、3、6、9、11、12、14、21、22、24は、ヒト好中球のスーパーオキシドアニオン産生を阻害し(IC50 ≤ 7.65 μg/mL)、1、9、11、14、21、22はエラスターゼ放出を阻害した(IC50 ≤ 3.23 μg/mL)。また、2、9、11、14、21はLPS誘導性のNO産生を強力に阻害し(IC50 ≤ 27.11 μM)、1、9、14はTNF-αとIL-6の産生も阻害した。さらに、1、9、14はMAPKsとIκBαの活性化を阻害し、M2マクロファージへの分化を促進した。これらの結果から、1、9、14はNO産生を標的とした抗炎症薬の開発候補となり得る。

この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。

抄録

Qin Pi (Fraxinus chinensis Roxb.) is commercially used in healthcare products for the improvement of intestinal function and gouty arthritis in many countries. Three new secoiridoid glucosides, (8E)-4''-O-methylligstroside (1), (8E)-4''-O-methyldemethylligstroside (2), and 3'',4''-di-O-methyl-demethyloleuropein (3), have been isolated from the stem bark of Fraxinus chinensis, together with 23 known compounds (4-26). The structures of the new compounds were established by spectroscopic analyses (1D, 2D NMR, IR, UV, and HRESIMS). Among the isolated compounds, (8E)-4''-O-methylligstroside (1), (8E)-4''-O-methyldemethylligstroside (2), 3'',4''-di-O-methyldemethyloleuropein (3), oleuropein (6), aesculetin (9), isoscopoletin (11), aesculetin dimethyl ester (12), fraxetin (14), tyrosol (21), 4-hydroxyphenethyl acetate (22), and (+)-pinoresinol (24) exhibited inhibition (IC50 ≤ 7.65 μg/mL) of superoxide anion generation by human neutrophils in response to formyl-L-methionyl-L-leuckyl-L-phenylalanine/cytochalasin B (fMLP/CB). Compounds 1, 9, 11, 14, 21, and 22 inhibited fMLP/CB-induced elastase release with IC50 ≤ 3.23 μg/mL. In addition, compounds 2, 9, 11, 14, and 21 showed potent inhibition with IC50 values ≤ 27.11 μM, against lipopolysaccharide (LPS)-induced nitric oxide (NO) generation. The well-known proinflammatory cytokines, tumor necrosis factor-alpha (TNF-α) and interleukin 6 (IL-6), were also inhibited by compounds 1, 9, and 14. Compounds 1, 9, and 14 displayed an anti-inflammatory effect against NO, TNF-α, and IL-6 through the inhibition of activation of MAPKs and IκBα in LPS-activated macrophages. In addition, compounds 1, 9, and 14 stimulated anti-inflammatory M2 phenotype by elevating the expression of arginase 1 and Krüppel-like factor 4 (KLF4). The above results suggested that compounds 1, 9, and 14 could be considered as potential compounds for further development of NO production-targeted anti-inflammatory agents.

MeSH

AnimalsAnti-Inflammatory AgentsCytochalasin BFraxinusGene Expression RegulationHumansInterleukin-6Iridoid GlucosidesKruppel-Like Factor 4Kruppel-Like Transcription FactorsLeukocyte ElastaseLipopolysaccharidesMAP Kinase Kinase 4MiceMolecular StructureN-Formylmethionine Leucyl-PhenylalanineNF-KappaB Inhibitor alphaNeutrophilsNitric OxidePlant BarkPlant ExtractsPrimary Cell CultureRAW 264.7 CellsStructure-Activity RelationshipSuperoxidesTumor Necrosis Factor-alphap38 Mitogen-Activated Protein Kinases

DOI 10.3390/molecules25245911

PMID 33327368

原文・出典を見る →